Search

everythinglearnresearchcommunity

for

Search:↓

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Botulinum toxin may help reduce skin flap damage caused by cigarette smoke.

Different types of persistent hair loss after chemotherapy respond differently to treatments.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Many patients with various medical conditions experience anxiety, which worsens their quality of life and raises healthcare costs.

Higher doses of isotretinoin may lead to more hair loss.

Low-dose oral minoxidil can be effective for hair loss but should be avoided in people with certain heart conditions and severe liver problems.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Most people in South India lack knowledge about managing COVID-19 at home.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Severe and early hair loss may indicate a higher risk of heart disease.

Alopecia areata may be linked to heart issues.

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Oral minoxidil is more convenient but topical minoxidil improves hair density better.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.